Literature DB >> 26060679

Serological Survey and Associated Risk Factors of Visceral Leish-maniasis in Qom Province, Central Iran.

Arash Rakhshanpour1, Mehdi Mohebali2, Behnaz Akhondi1, Mohammad Taghi Rahimi3, Mohammad Bagher Rokni2.   

Abstract

BACKGROUND: Visceral leishmaniasis (VL) or kala-azar is considered as a parasitic disease caused by the species of Leishmania donovani complex which is intracellular parasites. This systemic disease is endemic in some parts of provinc-es of Iran. The aim of this study was to determine the seroprevalence of VL in Qom Province, central Iran using di-rect agglutination test (DAT).
METHODS: Overall, 1564 serum samples (800 males and 764 females) were collected from selected subjects by random-ized cluster sampling in 2011-2012. Sera were tested and analyzed by DAT. Before sampling; a questionnaire was filled out for each case. Data were analyzed using Chi-square test and multivariate logistic regression for risk factors analysis.
RESULTS: Of 1564 individuals, 53 cases (3.38%) showed Leishmania specific antibodies as follows: with 1:400 titer 16 cases (1.02%), with 1:800 titer 20 cases (1.27%), with 1:1600 titer 16 cases (1.02%) whereas only one subject (0.06%) showed titers of ≥ 1:3200. There was no significant association between VL seropositivity and gender, age group and occupation. Binary logistic regression showed that rural areas was 0.44 times at higher risk of infection than urban areas (OR= 0.44; %95 CI= 0.25- 0.78).
CONCLUSION: Although the seroprevalence of VL is relatively low in Qom Province, yet due to the importance of the disease, the surveillance system should be monitored by health authorities.

Entities:  

Keywords:  Direct agglutination test; Human; Iran; Prevalence; Seroepidemiology; Visceral Leishmaniasis

Year:  2014        PMID: 26060679      PMCID: PMC4454043     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


Introduction

Visceral leishmaniasis (VL) or Dumdum fever is a vector-borne disease caused by the Leishmania infantumdonovani complex. VL is a systemic disease considered as the most devastating type of leishmaniasis, since it usually causes death in untreatedcases and many cases of deaths are left unrecognized (1). Even in cases of treatment, it may result in case-fatality rates of 10–20%. It is estimated that about 500,000 episodes and 59,000 deaths occur annually owing to this type of leishmaniasis (2). VL is the second-largest parasitic killer in the world following malaria (3). The clinical features of VL include fever, weight loss, fatigue, mucosal ulcers, anemia, and substantial hyperplasia of the liver and spleen that these symptoms can be easily mistaken with other febrile disease (4, 5). Of particular concern, based on the World Health Organization (WHO), is the emerging problem of HIV/VL co-infection and 34 countries reporting Leishmania/HIV co-infection worldwide (6). VL is a cosmopolitan disease and distributed in the Middle East region. In addition, domestic dogs (Canisfamiliaris) are known as major reservoir hosts of VL (4). Mediterranean VL is considered endemic in some areas of Iran including Ardabil (Moghan and Meshkin shahr), eastern Azerbaijan (Ahar and Kalibar), Bushehr (Dashti and Dashtestan) Fars (Darab, Firouzabad Noor abad and Jahrom), northern Khorasanand Qom (Khaljestan) districts. It has been reported sporadically in other provinces of the country (7-12). The aim of this study was to determine the seroprevalence and risk factors association of VL in Qom Province, central Iran using direct agglutination test (DAT).

Materials and Methods

Study area

Qom Province located on the south of Tehran and central Iran is of 11238 sq. km. The province is connected to the Semnan Province in the east, to the Isfahan Province in the south and to the Markazi Province from south-west to north-west (Fig.1). The population is estimated as one million. The province comprises of 1 city, 5 towns, 4 districts, and 936 habitationsout of which 356 are populated (Source: http://amar.sci.org.ir/index_e.aspx).
Fig. 1

Geographical locations of Qom Province in Iran where our serum samples were collected.

Geographical locations of Qom Province in Iran where our serum samples were collected.

Blood sampling

A cross-sectional study was performed on urban and rural populations of Qom Province in 2011-2012. Household data were obtained from local health authorities and one random person of one family out of twenty seven families was selected. Totally, 1564 serum samples (800 males and 764 females) were collected from 700 urban and 864 rural areas by randomized cluster sampling (Table 1 and 2).
Table 1

Study areas and number of collected serum for detection of seroprevalence of human visceral Leishmania infection in Qom Province

AreaNo. of sera
Urban700
Kahak264
Ghamrod&Ghanavat163
Ghaleecham&Salafcheghan154
Ghahan&Dastjerd151
Jaafarieh150
Total1564
Table 2

Distribution of studied population for detection of seroprevalence of human visceral Leishmania infantum infection by gender, residual area, occupation, dog keeping and education in Qom Province, central Iran

SexLocationOccupationDog keepingEducationTotal
MalefemaleUrbanRuralFarmerHouseholderSchoolingOtherYesNoEducatedIlliterate
80076470086420157116662818413808656991564
Study areas and number of collected serum for detection of seroprevalence of human visceral Leishmania infection in Qom Province Distribution of studied population for detection of seroprevalence of human visceral Leishmania infantum infection by gender, residual area, occupation, dog keeping and education in Qom Province, central Iran An informed consent document was taken from every participant. A questionnaire was filled out for each individual to obtain information then the blood sample was taken from each participant and transferred to sera separated the laboratory of the Amiralmomenin Polyclinic, Qom, Iran. Sera were sent to Leishmaniasis Laboratory, Dept. of Medical Parasitology, School of Public Health, Tehran University of Medical Sciences, Iran for examination with DAT.

Direct agglutination test (DAT)

DAT antigen was made in the Protozoalogy Unit of the School of Public Health, Tehran University of Medical Sciences. The principal phases of the procedure for preparing DAT antigen were mass production of promastigotes of Leishmania infantum(MCAN/IR/07/Moheb-gh.), (GenBank accession (no. FJ555210) (Iranian strain) in RPMI1640 plus 10% fetal bovine serum, tripsinization of the parasites, fixing with formaldehyde 2% and staining with Coomassie brilliant blue. The human sera were tested by DAT, initially, for screening purposes; dilutions were made at 1:400 and 1:3200 for human's samples. Negative control wells (antigen only) and known negative and positive controls were tested in each plate daily. The positive standard control serum was prepared from VL patients with L. infantum infection from the endemic areas. The cut off titer was determined as 1:3200, specific Leishmania antibodies at a titer of 1:3200 and upper were considered as positive (13, 14).

Statistical analysis

The data were analyzed using SPSS 16 program. Odds ratios for risk factors analysis were calculated by multivariate logistic regression model. P< 0.05 was considered as significant.

Results

Of 1564 individuals, 53 cases (3.38%) showed Leishmania specific antibodies as follows: with 1:400 titer 16 cases (1.02%), with 1:800 titer 20 cases (1.27%), with 1:1600 titer 16 cases (1.02%) whereas only one subject (0.06%) showed titers of ≥ 1:3200 (Table 3 and 4). Therefore considering the cut off titer, only one sample was regarded as positive case which belongs to a 30 years- old educated man who resides in Kahak and with no history of keeping dog.
Table 3

Frequencyof anti-Leishmania antibodies titers using DAT by residual area in Qom Province, central Iran

Residual area1:400(%)1:800(%)1:1600(%)1:3200(%)Total(%)
Urban40.25150.96150.9600342.17
Rural120.7750.3110.0610.06191.21
Total161.02201.28161.0210.06533.38
Table 4

Seroprevalence of human visceral Leishmania infection by direct agglutination test (DAT ≥ 1:3200) with anti-Leishmania infantum antibodies by gender in Qom Province

GenderNo. examinedAnti-Leishmania antibody titersTotal
1:4001:8001:1600≥1:3200
No.Prevalence (%)No.Prevalence (%)No.Prevalence (%)No.Prevalence (%)No.Prevalence (%)
Male800101210133
0.630.760.630.062.1
Female7646860020
0.380.510.381.27
Total1564162016153
1.011.281.010.063.38
Frequencyof anti-Leishmania antibodies titers using DAT by residual area in Qom Province, central Iran Seroprevalence of human visceral Leishmania infection by direct agglutination test (DAT ≥ 1:3200) with anti-Leishmania infantum antibodies by gender in Qom Province Furthermore, in urban areas 34 subjects (2.17%) showed a titers of ≥ 1:400 while in rural areas were 18 cases including Kahak one sample (0.4%), Ghahan&Dastjerd 11 samples (7.3%), Ghamrod&Ghanavat 5 samples (3.1%) and Jaafarieh one sample (0.7%). There was no significant association between VL seropositivity and gender, age group and occupation. Binary logistic regression showed that rural areas was 0.44 times at higher risk of infection than urban areas (OR= 0.44; %95 CI= 0.25- 0.78).

Discussion

In the current study from 1564 collected human serum samples, 1 sample showed anti-Leishmania antibodies at titers of ≥ 1:3200 whereas 52 samples (3.3%) revealed anti-Leishmania infantum antibodies at titers of ≥ 1:400. Meanwhile, 16 (2.1%) subjects revealed titer of 1:1600 which is considered as suspicious cases. In this study, males showed more anti-Leishmania specific antibodies compared to females that is in consistent with other studies (15, 16). This survey showed that one case in rural areas had anti-Leishmania antibodies at titer 1:3200 in comparison with urban areas (0 case) (P= 0.007). Besides, rural areas was 0.44 times at higher risk to be infected than urban areas (OR= 0.44; %95 CI= 0.25- 0.78) and multivariate analysis showed that rural areas was 0.45 times at higher risk of infection than urban areas (OR= 0.45; %95 CI=0.23-0.89). This fact may be associated hygienic level in rural areas. There was no significant association between VL seropositivity, sex and age group. According to literature review the seroprevalence of VL using DAT at titers ≥ 1:3200 in other parts of the Iran was as follows: Mazandaran Province 0.% (17), Kermanshah Province0.33% (18), Khorasan Province [Bojnurd and Shirvan, 0.46%] (13),Kerman Province [Baft 0.95%] (19), ChaharMahal&Bakhtiari province [Poshtkuh 1.3%] (20), Kohgiloyeh&Bouirahmad Province 3.1% (21), Bushehr Province [Dashti and Dashtestan 3.4%] (10), Ardabil Province [Germi 2.8%, Meshkinshahr 6.3%, Pars- Abad and Khalkhal 5.1%] (7). In addition, a similar investigation was carried out on 416 human sera samples in 8 villages of Ghahan, Qom Province using DAT for detection of Leishmania antibodies. Totally, 7 cases (1.7%) were positive with titers 1:3200 and above that three of seropositive cases had a previous history of VL (12). Our findings indicated that the rate of seropositivity in Qom Province is fewer than all above mentioned areas except Mazandaran Province. In the present study, DAT was employed to detect Leishmania antibodies for a couple of reasons. Two main features of serological methods, being highly sensitive and non-invasive, make them appropriate for use in field conditions (13). The various serological methods including ELISA, DAT and IFAT (indirect fluorescent antibody test) are available for diagnosis of VL. Due to simplicity, validity, economical benefits, high sensitivity and specificity, DAT was used in several epidemiologic studies in Iran with large-scale screening of human. The sensitivity and specificity of this assay at cut-off titer 1:3200 varies between 90–100% and 72–100% respectively (22, 23).

Conclusion

The present study showed that the risk of VL is still remained in this region. To control VL in this area, further investigation on sand flies fauna and canines as reservoir hosts of VL are highly recommended, and also treatment of suspected human cases should be considered. Continuous serological researches and preventive measures should be taken into consideration owing to the significance of the disease.
  13 in total

Review 1.  Laboratory diagnosis of visceral leishmaniasis.

Authors:  Shyam Sundar; M Rai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 2.  Diagnosis of visceral leishmaniasis.

Authors:  Pankaj Srivastava; Anand Dayama; Sanjana Mehrotra; Shyam Sundar
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-11       Impact factor: 2.184

Review 3.  The increase in risk factors for leishmaniasis worldwide.

Authors:  P Desjeux
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.184

4.  Seroepidemiological study of visceral leishmaniasis in Booyerahmad district, south-west Islamic Republic of Iran.

Authors:  B Sarkari; N Pedram; M Mohebali; A A Moshfe; M A Zargar; B Akhoundi; M R Shirzadi
Journal:  East Mediterr Health J       Date:  2010-11       Impact factor: 1.628

5.  Seroepidemiological study of visceral leishmaniasis among humans and animal reservoirs in Bushehr province, Islamic Republic of Iran.

Authors:  M Mohebali; Y Hamzavi; G H Edrissian; A Forouzani
Journal:  East Mediterr Health J       Date:  2001-11       Impact factor: 1.628

6.  Comparison of real-time PCR and conventional PCR with two DNA targets for detection of Leishmania (Leishmania) infantum infection in human and dog blood samples.

Authors:  A Mohammadiha; M Mohebali; A Haghighi; R Mahdian; A R Abadi; Z Zarei; F Yeganeh; B Kazemi; N Taghipour; B Akhoundi
Journal:  Exp Parasitol       Date:  2012-11-15       Impact factor: 2.011

7.  Epidemiological aspects of kala-azar in Meshkin-Shahr, Iran: human infection.

Authors:  G Soleimanzadeh; G H Edrissian; A M Movahhed-Danesh; A Nadim
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

Review 8.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

9.  Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan.

Authors:  Simon Collin; Robert Davidson; Koert Ritmeijer; Kees Keus; Yosef Melaku; Sammy Kipngetich; Clive Davies
Journal:  Clin Infect Dis       Date:  2004-02-12       Impact factor: 9.079

10.  Epidemiological aspects of visceral leishmaniasis in baft district, kerman province, southeast of iran.

Authors:  H Mahmoudvand; M Mohebali; I Sharifi; H Keshavarz; H Hajjaran; B Akhoundi; S Jahanbakhsh; M Zarean; A Javadi
Journal:  Iran J Parasitol       Date:  2011-03       Impact factor: 1.012

View more
  6 in total

1.  Geographic and ecological features of phlebotomine sand flies (Diptera: Psychodidae) as leishmaniasis in Central Iran.

Authors:  Hassan Vatandoost; Jalil Nejati; Abedin Saghafipour; Alireza Zahraei-Ramazani
Journal:  J Parasit Dis       Date:  2017-10-26

2.  Seroepidemiological study on visceral leishmaniasis in an endemic focus of central Iran during 2017.

Authors:  Leyli Zanjirani Farahani; Mehdi Mohebali; Behnaz Akhoundi; Abedin Saghafipour; Zahra Kakooei
Journal:  J Parasit Dis       Date:  2018-11-10

3.  Investigation of Visceral Leishmaniasis among 192 Dog Carcasses Killed by Road Accidents in Khorasan Razavi, Northeastern Iran during 2014-2016.

Authors:  Elham Moghaddas; Abdolmajid Fata; Mehdi Zarean; Majid Derakhshani; Mahdi Fakhar; Seyed Aliakbar Shamsian
Journal:  Iran J Public Health       Date:  2018-11       Impact factor: 1.429

Review 4.  Factors associated with the expansion of leishmaniasis in urban areas: a systematic and bibliometric review (1959-2021).

Authors:  Marília Schutz Borges; Luana Budny Niero; Laíse Dimer Sant'ana da Rosa; Vanilde Citadini-Zanette; Guilherme Alves Elias; Patrícia de Aguiar Amaral
Journal:  J Public Health Res       Date:  2022-08-30

Review 5.  Visceral Leishmaniasis in Southeastern Iran: A Narrative Review.

Authors:  Iraj Sharifi; Mohammad Reza Aflatoonian; Mohammad Hossein Daei Parizi; Ali Hosseininasab; Mahshid Mostafavi; Mehdi Bamorovat; Abass Aghaei Afshar; Mehdi Mohebali; Hossein Keshavarz; Hamid Daneshvar; Zahra Babaei; Hossein Mahmoudvand; Mohammad Ali Mohammadi; Fatemeh Sharifi; Mohammad Barati; Hossein Kamiabi; Tabandeh Khaleghi
Journal:  Iran J Parasitol       Date:  2017 Jan-Mar       Impact factor: 1.012

6.  Asymptomatic Leishmania Infected Children: A Seroprevalence and Molecular Survey in a Rural Area of Fars Province, Southern Iran.

Authors:  Akram Layegh Gigloo; Bahador Sarkari; Zahra Rezaei; Gholam Reza Hatam; Mohammad Hassan Davami
Journal:  J Trop Med       Date:  2018-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.